AdaptHealth Corp. (AHCO) vs Gyre Therapeutics, Inc. (GYRE)
A side-by-side comparison of AdaptHealth Corp. and Gyre Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.86HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
GYRE
Gyre Therapeutics, Inc.
$7.16HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — AHCO vs GYRE
growth of $100 · dividends reinvested · last 8yAHCO -40.8% (-6.3%/yr)GYRE -85.3% (-21.3%/yr)AHCO compounded faster over this window
AHCO GYRE
AHCO vs GYRE: by the numbers
- •GYRE is the larger company ($798M vs $797M market cap).
- •Both run net losses; AHCO's is the smaller (-7.58% vs -14.52% net margin).
- •GYRE grew revenue faster over the past five years (84.92% vs 11.68% CAGR).
Metrics side by side
Valuation
| Metric | AHCO | GYRE |
|---|---|---|
| P/S ratio | 0.26 | 6.68 |
| P/B ratio | 0.58 | 7.39 |
| EV / EBITDA | 6.66 | N/A |
| FCF yield | 12.25% | N/A |
Profitability
| Metric | AHCO | GYRE |
|---|---|---|
| Gross margin | 10.37% | 94.30% |
| Operating margin | -0.31% | 9.86% |
| Net margin | -7.58% | -14.52% |
| ROE | -16.56% | -13.30% |
| ROIC | -0.26% | -9.77% |
Growth (annualized)
| Metric | AHCO | GYRE |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | 84.92% |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | -0.34% |
Frequently asked
- Which has grown faster, AHCO or GYRE?
- Over the past five years, GYRE grew revenue faster — AHCO at a 11.68% CAGR versus GYRE at 84.92%.
- How have AHCO and GYRE total returns compared?
- Over the past 5 years, AHCO delivered -24.65% and GYRE delivered -0.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AdaptHealth ROEGyre Therapeutics ROEAdaptHealth operating marginGyre Therapeutics operating marginAdaptHealth revenue growthGyre Therapeutics revenue growthAdaptHealth free cash flowGyre Therapeutics free cash flow
AdaptHealth & Gyre Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.